Very recently, based on specific HLA/KIR subtype combinations, a predictive algorithm for donor selection has been developed in a cohort of 1,328 patients with AML who received HLA-matched SCT transplant (30). This evidence concerns the gene KIR3DL1 and acute myeloid leukemia.